ArticleBMC infectious diseases2026
Exploring determinants of quality of life for virally suppressed people with HIV in Northern Taiwan.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundWith the success of antiretroviral therapy (ART), quality of life (QoL) has become a central goal in HIV care under the “Fourth 90” framework. While Taiwan has made significant strides in achieving UNAIDS targets, QoL among people with HIV (PWH) remains an ongoing challenge. This study explored determinants of QoL among virally suppressed PWH in Taiwan.
methodsA cross-sectional study was conducted a major HIV clinic in Taipei, enrolling 767 virally suppressed PWH between December 2018 and June 2021. Viral suppression was defined as an HIV RNA level of < 40 copies/mL, quantified using a standardized RT-PCR assay, measured within 6 months prior to enrollment. QoL was assessed using the World Health Organization Quality of Life Scale – brief version (WHOQOL-BREF), depressive symptoms using the validated Center for Epidemiologic Studies Depression Scale (CES-D), and medication adherence using the Medication Adherence Report Scale (MARS-5). Sociodemographic and clinical characteristics were collected through structured interviews. Multivariable linear regression analyses were performed to identify factors associated with QoL domains.
resultsOverall, 78.5% of participants reported good self-perceived QoL. Depressive symptoms were the strongest factor associated with lower QoL across all four domains (physical, psychological, social, and environmental), with reductions of approximately 2–3 points per domain. Higher income and educational attainment were associated with better QoL. Marriage and having a romantic partner were associated with higher psychological and social well-being.
conclusionsAmong virally suppressed PWH in Taiwan, depressive symptoms, socioeconomic factors, and relationship status were strongly associated with QoL. These findings support the integration of routine depression screening, financial aid expansion, education-related support, and inclusive relationship policies into HIV care to advance the Fourth 90 goal of optimizing quality of life. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.